4.6 Article

Comparison of Four Carbapenemase Detection Methods for blaKPC-2 Variants

Related references

Note: Only part of the references are listed.
Article Infectious Diseases

Carbapenemase detection testing in the era of ceftazidime/avibactam-resistant KPC-producing Enterobacterales: A 2-year experience

Gabriele Bianco et al.

Summary: This study aimed to investigate the prevalence of CZA resistance among carbapenemase-producing Enterobacterales (CPE) blood culture isolates and evaluate the performance of carbapenemase phenotypic detection methods. The study found a high CZA resistance rate and identified specific results associated with different KPC variants, suggesting a diagnostic algorithm involving molecular bla(KPC) identification followed by phenotypic assay for efficient detection.

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2021)

Article Microbiology

Characterization of KPC-82, a KPC-2 Variant Conferring Resistance to Ceftazidime-Avibactam in a Carbapenem-Nonsusceptible Clinical Isolate of Citrobacter koseri

Francois Lebreton et al.

Summary: KPC-82 is a KPC-2 variant found in a carbapenem-nonsusceptible Citrobacter koseri, conferring high-level resistance to ceftazidime-avibactam. The bla(KPC-82) gene is carried on a chromosomally integrated Tn4401 transposon, resulting in a two-amino-acid insertion caused by a nucleotide tandem repeat. Despite decreased carbapenemase activity in a heterologous background, KPC-82 remains susceptible to carbapenem/beta-lactamase inhibitor combinations.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

Article Microbiology

Epidemiology of Carbapenem Resistance Determinants Identified in Meropenem-Nonsusceptible Enterobacterales Collected as Part of a Global Surveillance Program, 2012 to 2017

Krystyna M. Kazmierczak et al.

Summary: The study estimated the incidence of carbapenem-resistant Enterobacterales globally and found that the resistance mechanisms varied by region, with KPC-type, metallo-beta-lactamases, and OXA-48-like beta-lactamases being the main contributors. The overall percentage of meropenem-nonsusceptible Enterobacterales increased from 2012 to 2017, with different carbapenemase types showing increasing proportions in different regions.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

Article Infectious Diseases

Molecular analysis of clinical isolates of ceftazidime-avibactam-resistant Klebsiella pneumoniae

Carolina Venditti et al.

Summary: The study analyzed ceftazidime-avibactam-resistant KPC-producing Klebsiella pneumoniae strains collected from 31 patients in six hospitals in Rome, revealing mutations in KPC variants within the bla(KPC-3) gene and the presence of high-risk clones (ST512, 101, and 307). The findings highlight concerns over the potential selection of a multidrug-resistant phenotype in strains showing resistance to both ceftazidime-avibactam and carbapenems.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Review Microbiology

New beta-Lactam-beta-Lactamase Inhibitor Combinations

Dafna Yahav et al.

CLINICAL MICROBIOLOGY REVIEWS (2020)

Article Infectious Diseases

Unravelling ceftazidime/avibactam resistance of KPC-28, a KPC-2 variant lacking carbapenemase activity

Saoussen Oueslati et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)

Article Infectious Diseases

Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections

D. Ben-David et al.

CLINICAL MICROBIOLOGY AND INFECTION (2012)

Article Immunology

Rapid Detection of Carbapenemase-producing Enterobacteriaceae

Patrice Nordmann et al.

EMERGING INFECTIOUS DISEASES (2012)

Article Microbiology

Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital

Azita Leavitt et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)